Why one trial participant's healthy birth after her CAR-T treatment for lupus is catching resesarchers' attention: ...

Prevent Blindness has designated November 18 to 24, 2024, as the 5th annual Thyroid Eye Disease (TED) Awareness Week. The ...

HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing ...

It just feels like it didn’t have to come to this. I feel like, as a father, I waited way too long for insurance to give us a ...

whereas diets abundant in processed foods and sugars can disrupt this equilibrium. Researchers are discovering that ...

Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today announced the ...

Anish Suri, Ph.D., president & chief scientific officer (CSO) of Cue Biopharma, to transition to principal research and immunology advisor BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.

Calling the lack of education around this tenet of our health “the biggest blind spot in the Western conventional healthcare ...

Autoimmune illnesses are thought to be caused by a combination ... Maintaining a healthy lifestyle, which includes a well-balanced diet rich in anti-inflammatory foods, frequent exercise and stress ...

New and in-the-pipeline Janus kinase (JAK) inhibitors have the potential to make huge differences in the lives of patients ...

Following patient deaths in a lupus trial that led to the termination of that program, Kezar’s autoimmune candidate ...

The agency has placed a partial hold on the phase 2a PORTOLA trial evaluating the selective immunoproteasome inhibitor ...